These key biomarkers include Aβ 40 and Aβ 42, and markers of AD-related metabolic disorders, T-tau (total) [38], and different phosphorylated forms of P-tau like phosphorylated at Thr-181 [39,40] and at Ser-396 [41,42]. This evidence concerns the gene MAPT and Alzheimer disease.